基于内皮糖体的流失量化对症相关的扩散性血管内凝血的抗凝血疗法的重新评估:单中心,回顾性,观察性试点研究
Keiko Suzuki1,2, Akio Suzuki3, Kazuyuki Sumi3
1Practical Pharmaceutical Research Center, Gifu Pharmaceutical University, Gifu, Japan.
Frontiers in medicine
|July 31, 2025
概括
血清中syndecan-1的水平可能表明从与败血症相关的扩散性血管内凝血 (DIC) 中恢复. 较低的治疗后syndecan-1水平与恢复相关,而增加表明接受抗凝药的患者的结果不佳.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 败血症引起的传播性血管内凝血 (DIC) 呈现出一种高死亡率的危急状况.
- 目前用于治疗与败血症相关的DIC的抗凝药治疗 (复合人体溶性血栓模块素[rhTM],抗血栓素) 有争议的疗效.
- Syndecan-1是内皮糖损伤的标志物,是败血症严重程度和预后的潜在指标.
研究的目的:
- 为了研究血清中syndecan-1水平与在接受抗凝药治疗的患者中与败血症相关的DIC恢复之间的关联.
- 评估syndecan-1作为一种潜在的生物标志物,用于监测败血症相关的DIC的治疗反应和预后.
主要方法:
- 一项回顾性观察性研究包括13名成年患有败血症相关的DIC患者,他们接受了至少2天的抗凝剂 (rhTM,抗血III) 治疗.
- 血清中syndecan-1水平在基线,治疗期间和治疗后2天被测量.
- 在使用日本急性医学协会 (JAAM) -2和JAAM-DIC标准评估DIC的恢复.
主要成果:
- 血清中syndecan-1水平在抗凝药开始时达到峰值,在治疗期间下降,并在治疗停止后上升.
- 从DIC中恢复与较低的治疗后syndecan-1水平显著相关 (p <0.05).
- 没有康复的患者显示syndecan-1水平增加了30%以上,与死亡率相关.
结论:
- Syndecan-1 作为一种潜在的标记物,用于监测结质内皮损伤和与败血症相关的 DIC.中恢复.
- 延长抗凝剂治疗可能通过减轻内皮损伤和促进DIC恢复来改善结果.
- 需要进一步的大规模研究来验证这些发现和临床实用性.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
01:30Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24